FDA Approved: TIZANIDINE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application for tizanidine submitted by Apotex Corp. This action approves the changes described in the supplemental filing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Spasticity
• Spinal Cord Injury

Drugs mentioned

• TIZANIDINE (TIZANIDINE)

Snippet

SUPPL AP for TIZANIDINE (TIZANIDINE)